- 51-200 Employees
- Based in Shanghai, China
I-Mab (Nasdaq: IMAB) is a dynamic, global biotech company exclusively focused on discovery, development and soon commercialization of novel or highly differentiated biologics in immuno-oncology. The Company’s mission is to bring transformational medicines to patients around the world through innovation. I-Mab’s innovative pipeline of more than 10 clinical and pre-clinical stage drug candidates…More
Most Recent Responsibility Report
2021 Environmental, Social & Governance Report
Report Locked. I-MAB has reached its limit for free report views.
I-MAB does not currently have any hardcopy reports on ResponsibilityReports.com. Click the button below to request a report when hardcopies become available.
Please fill out the form below and click "Place Order" to complete your order.
Our service enables potential investors to review the most recent and archived I-MAB Sustainability Report, I-MAB Corporate Social Responsibility Report, I-MAB CSR Report, I-MAB Corporate Responsibility, I-MAB CR Report, I-MAB Citizenship Report, I-MAB ESG Report, and I-MAB Environmental Report online.